Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Boehringer Ingelheim
Eli Lilly and Company
Pfizer
Memorial Sloan Kettering Cancer Center
Servier
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
ModernaTX, Inc.
Genmab
Ohio State University Comprehensive Cancer Center
Bayer
Werewolf Therapeutics, Inc.
Novartis
Sandoz
M.D. Anderson Cancer Center
City of Hope Medical Center
Eli Lilly and Company
Mayo Clinic
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
H. Lee Moffitt Cancer Center and Research Institute
University of Southern California
Royal Marsden NHS Foundation Trust
Novartis
Bayer
Merck Sharp & Dohme LLC
D2M Biotherapeutics Inc.
Syntrix Biosystems, Inc.
TILT Biotherapeutics Ltd.
Amgen
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
University of Florida
Cullinan Therapeutics Inc.
Seattle Children's Hospital
Amgen
Providence Health & Services
Daiichi Sankyo
Jonsson Comprehensive Cancer Center
Nanobiotix
Amgen
Vividion Therapeutics, Inc.
M.D. Anderson Cancer Center
Massachusetts General Hospital
Microbiotica Ltd
Asher Biotherapeutics, Inc.